Pleural disorders encompass a variety of conditions affecting the thin membrane lining the lungs and chest cavity, leading to altered lung mechanics, impaired ventilation, and respiratory discomfort. Common pleural conditions include pleural effusion, pneumothorax, pleuritis, and pleural fibrosis, each with unique mechanisms and clinical implications. These disorders can result from infections, malignancies, trauma, autoimmune diseases, or chronic systemic illnesses, and they often present with chest pain, shortness of breath, and diminished breath sounds on physical examination. Diagnosis of pleural disorders integrates clinical evaluation with imaging and laboratory investigations. Chest X-rays, ultrasound, and computed tomography provide insight into fluid accumulation, air leaks, or thickening of the pleural layers. Analysis of pleural fluid obtained via thoracentesis can differentiate transudative from exudative effusions, guiding targeted treatment. In selected cases, pleural biopsy or thoracoscopy may be necessary for definitive diagnosis, especially in suspected malignancy or chronic inflammatory conditions.
Management strategies are tailored to the underlying cause and the severity of symptoms. Therapeutic approaches include pleural fluid drainage, chest tube placement, antibiotics for infections, anti-inflammatory agents, and, in chronic or recurrent cases, pleurodesis or surgical intervention. Supportive care, including oxygen supplementation and pain management, is often necessary to maintain respiratory function. Recent advances in minimally invasive techniques, imaging guidance, and targeted therapies have enhanced the safety and effectiveness of interventions. By integrating accurate diagnosis, individualized therapy, and supportive care, the management of pleural disorders aims to restore lung function, relieve symptoms, and address the underlying pathology.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation